# PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis

> **NCT03027635** · NA · TERMINATED · sponsor: **Nina Kimer** · enrollment: 13 (actual)

## Conditions studied

- Cirrhosis
- Ascites Hepatic
- Ascites (Non-Malignant)

## Interventions

- **DEVICE:** PleurX, peritoneal tunnelated catheter
- **DEVICE:** Large Volume Paracentesis
- **DRUG:** Ciprofloxacin 500Mg Tablet

## Key facts

- **NCT ID:** NCT03027635
- **Lead sponsor:** Nina Kimer
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-20
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-05-15
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Slow recruitment and limited funding. The treatment intervention is instituted in clinical practice as and end-stage treatment option at hospitals in Denmark
- **Last updated:** 2019-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03027635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03027635, "PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03027635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*